Ascendis Pharma (ASND) Q4 2025 Earnings Transcript
Source: Motley Fool
2026-02-11 19:50:19 ET
Image source: The Motley Fool.
Wednesday, February 11, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Ascendis Pharma A/S
NASDAQ: ASND
ASND Trading
2.51% G/L:
$227.47 Last:
230,916 Volume:
$229.95 Open:
ASND Latest News
February 27, 2026 05:57:16 pm
FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
February 11, 2026 04:01:00 pm
Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results
ASND Stock Data
$13,394,473,228
60,082,592
N/A
105
N/A
Biotechnology & Life Sciences
Healthcare
DK
Hellerup
